Signal / reference entry

Dulaglutide

Also listed as Trulicity

Start with the scope. Follow the sources. Use the reading note to examine how a claim is supported.

Reference fields

View sources

Approval labels are specific to a product, route, and use. Read the scope and limitations together.

Status for this entry
Approved product
Evidence label
Randomized evidence

Status as of

Product and use
Trulicity: specified type 2 diabetes populations.
Route context
Subcutaneous injection.
Mechanism
GLP-1 receptor agonist fusion protein.
Evidence
Randomized studies.
Limitations
No weight-management indication.
Safety
Not recommended for severe gastroparesis.

Sources for these reference fields

Read beyond the claim

A closer reading

A missing citation leaves a gap in the claim you are checking. Keep that observation separate from any conclusion about the entire research record. First identify what kind of support the sentence would require, then look for a report that addresses that particular question. If your search remains incomplete, describe the limit of the search instead of declaring the question settled. This approach gives you a useful stopping point: the claim has not been traced through the material you examined. It also leaves room to assess additional evidence on its own terms.

Questions to take to the source

  1. What kind of evidence would support the specific sentence being checked?
  2. Have I documented a missing citation or established something broader?
  3. How can I describe the limits of my search accurately?

Filed under

  • Metabolism

Topics organize the index; they do not describe a recommended use.

Sources

These references support the reference fields as a group. Follow each link to inspect its scope and wording.

  1. TRULICITY NLM · Checked

Educational reference material. No clinician review is claimed. This entry does not provide personal medical advice.